Zobrazeno 1 - 10
of 103
pro vyhledávání: '"Braun, Dominique"'
Autor:
Paioni, Paolo, Aebi-Popp, Karoline, Martinez de Tejada, Begoña, Rudin, Christoph, Bernasconi, Enos, Braun, Dominique L, Kouyos, Roger, Wagner, Noémie, Crisinel, Pierre Alex, Güsewell, Sabine, Darling, Katharine E A, Duppenthaler, Andrea, Baumann, Marc, Polli, Christian, Fischer, Tina, Kahlert, Christian R
Publikováno v:
Paioni, Paolo; Aebi-Popp, Karoline; Martinez de Tejada, Begoña; Rudin, Christoph; Bernasconi, Enos; Braun, Dominique L; Kouyos, Roger; Wagner, Noémie; Crisinel, Pierre Alex; Güsewell, Sabine; Darling, Katharine E A; Duppenthaler, Andrea; Baumann, Marc; Polli, Christian; Fischer, Tina; Kahlert, Christian R (2023). Viral suppression and retention in HIV care during the postpartum period among women living with HIV: a longitudinal multicenter cohort study. The Lancet regional health. Europe, 31, p. 100656. Elsevier 10.1016/j.lanepe.2023.100656
BACKGROUND Low rates of postnatal retention in HIV care and viral suppression have been reported in women living with HIV (WLWH) despite viral suppression at delivery. At the same time, postpartum follow-up is of crucial importance in light of the in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efa350810312305c244a0b8457f7927c
https://boris.unibe.ch/183336/1/1-s2.0-S2666776223000753-main.pdf
https://boris.unibe.ch/183336/1/1-s2.0-S2666776223000753-main.pdf
Autor:
Gracia-Diaz, Carolina, Zhou, Yijing, Yang, Qian, Maroofian, Reza, Espana-Bonilla, Paula, Lee, Chul-Hwan, Zhang, Shuo, Padilla, Natàlia, Fueyo, Raquel, Waxman, Elisa A, Lei, Sunyimeng, Otrimski, Garrett, Li, Dong, Sheppard, Sarah E, Mark, Paul, Harr, Margaret H, Hakonarson, Hakon, Rodan, Lance, Jackson, Adam, Vasudevan, Pradeep, Powel, Corrina, Mohammed, Shehla, Maddirevula, Sateesh, Alzaidan, Hamad, Faqeih, Eissa A, Efthymiou, Stephanie, Turchetti, Valentina, Rahman, Fatima, Maqbool, Shazia, Salpietro, Vincenzo, Ibrahim, Shahnaz H, di Rosa, Gabriella, Houlden, Henry, Alharbi, Maha Nasser, Al-Sannaa, Nouriya Abbas, Bauer, Peter, Zifarelli, Giovanni, Estaras, Conchi, Hurst, Anna C E, Thompson, Michelle L, Chassevent, Anna, Smith-Hicks, Constance L, de la Cruz, Xavier, Holtz, Alexander M, Elloumi, Houda Zghal, Hajianpour, M J, Rieubland, Claudine, Braun, Dominique, Banka, Siddharth, French, Deborah L, Heller, Elizabeth A, Saade, Murielle, Song, Hongjun, Ming, Guo-Li, Alkuraya, Fowzan S, Agrawal, Pankaj B, Reinberg, Danny, Bhoj, Elizabeth J, Martínez-Balbás, Marian A, Akizu, Naiara
Publikováno v:
Gracia-Diaz, Carolina; Zhou, Yijing; Yang, Qian; Maroofian, Reza; Espana-Bonilla, Paula; Lee, Chul-Hwan; Zhang, Shuo; Padilla, Natàlia; Fueyo, Raquel; Waxman, Elisa A; Lei, Sunyimeng; Otrimski, Garrett; Li, Dong; Sheppard, Sarah E; Mark, Paul; Harr, Margaret H; Hakonarson, Hakon; Rodan, Lance; Jackson, Adam; Vasudevan, Pradeep; ... (2023). Gain and loss of function variants in EZH1 disrupt neurogenesis and cause dominant and recessive neurodevelopmental disorders. Nature Communications, 14(1), p. 4109. Springer Nature 10.1038/s41467-023-39645-5
Genetic variants in chromatin regulators are frequently found in neurodevelopmental disorders, but their effect in disease etiology is rarely determined. Here, we uncover and functionally define pathogenic variants in the chromatin modifier EZH1 as t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a7c45e8400d20312e21d9446fcacebd
https://boris.unibe.ch/184706/1/s41467-023-39645-5.pdf
https://boris.unibe.ch/184706/1/s41467-023-39645-5.pdf
Autor:
van Santen, Daniela K, Sacks-Davis, Rachel, Stewart, Ashleigh, Boyd, Anders, Young, Jim, van der Valk, Marc, Smit, Colette, Rauch, Andri, Braun, Dominique L, Jarrin, Inmaculada, Berenguer, Juan, Lazarus, Jeffrey V, Lacombe, Karine, Requena, Maria-Bernarda, Wittkop, Linda, Leleux, Olivier, Salmon, Dominique, Bonnet, Fabrice, Matthews, Gail, Doyle, Joseph S, Spelman, Tim, Klein, Marina B, Prins, Maria, Asselin, Jason, Stoové, Mark A, Hellard, Margaret, InCHEHC study group
Publikováno v:
EClinicalMedicine
EClinicalMedicine, 2023, 56, pp.101810. ⟨10.1016/j.eclinm.2022.101810⟩
van Santen, Daniela K; Sacks-Davis, Rachel; Stewart, Ashleigh; Boyd, Anders; Young, Jim; van der Valk, Marc; Smit, Colette; Rauch, Andri; Braun, Dominique L; Jarrin, Inmaculada; Berenguer, Juan; Lazarus, Jeffrey V; Lacombe, Karine; Requena, Maria-Bernarda; Wittkop, Linda; Leleux, Olivier; Salmon, Dominique; Bonnet, Fabrice; Matthews, Gail; Doyle, Joseph S; ... (2023). Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019. EClinicalMedicine, 56, p. 101810. Elsevier 10.1016/j.eclinm.2022.101810
EClinicalMedicine, 56:101810. Lancet Publishing Group
EClinicalMedicine, 2023, 56, pp.101810. ⟨10.1016/j.eclinm.2022.101810⟩
van Santen, Daniela K; Sacks-Davis, Rachel; Stewart, Ashleigh; Boyd, Anders; Young, Jim; van der Valk, Marc; Smit, Colette; Rauch, Andri; Braun, Dominique L; Jarrin, Inmaculada; Berenguer, Juan; Lazarus, Jeffrey V; Lacombe, Karine; Requena, Maria-Bernarda; Wittkop, Linda; Leleux, Olivier; Salmon, Dominique; Bonnet, Fabrice; Matthews, Gail; Doyle, Joseph S; ... (2023). Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019. EClinicalMedicine, 56, p. 101810. Elsevier 10.1016/j.eclinm.2022.101810
EClinicalMedicine, 56:101810. Lancet Publishing Group
BACKGROUND Broad direct-acting antiviral (DAA) access may reduce hepatitis C virus (HCV) incidence through a "treatment as prevention" (TasP) effect. We assessed changes in primary HCV incidence following DAA access among people living with HIV (PLHI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8dc6dc014c030b8f02045b7106c10dd
https://hal.science/hal-03943619/document
https://hal.science/hal-03943619/document
Autor:
Schoepf, Isabella C, Thorball, Christian W, Kovari, Helen, Ledergerber, Bruno, Buechel, Ronny R, Calmy, Alexandra, Weber, Rainer, Kaufmann, Philipp A, Nkoulou, René, Schwenke, Johannes M, Braun, Dominique L, Fellay, Jacques, Tarr, Philip E, Swiss HIV Cohort Study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______885::01d215dc7419afe5392a3dd1d247ae5a
https://doi.org/10.5167/uzh-223114
https://doi.org/10.5167/uzh-223114
Autor:
Schoepf, Isabella C., Esteban-Cantos, Andres, Thorball, Christian W., Rodes, Berta, Reiss, Peter, Rodriguez-Centeno, Javier, Riebensahm, Carlotta, Braun, Dominique L., Marzolini, Catia, Seneghini, Marco, Bernasconi, Enos, Cavassini, Matthias, Buvelot, Helene, Thurnheer, Maria Christine, Kouyos, Roger D., Fellay, Jacques, Gunthard, Huldrych F., Arribas, Jose R., Ledergerber, Bruno, Tarr, Philip E.
Publikováno v:
Schoepf, Isabella C; Esteban-Cantos, Andrés; Thorball, Christian W; Rodés, Berta; Reiss, Peter; Rodríguez-Centeno, Javier; Riebensahm, Carlotta; Braun, Dominique L; Marzolini, Catia; Seneghini, Marco; Bernasconi, Enos; Cavassini, Matthias; Buvelot, Hélène; Thurnheer, Maria Christine; Kouyos, Roger D; Fellay, Jacques; Günthard, Huldrych F; Arribas, José R; Ledergerber, Bruno and Tarr, Philip E (2023). Epigenetic ageing accelerates before antiretroviral therapy and decelerates after viral suppression in people with HIV in Switzerland: a longitudinal study over 17 years. The Lancet. Healthy longevity, 4(5), e211-e218. Elsevier 10.1016/S2666-7568(23)00037-5
Background Accelerated epigenetic ageing can occur in untreated HIV infection and is partially reversible with effective antiretroviral therapy (ART). We aimed to make a long-term comparison of epigenetic ageing dynamics in people with HIV during unt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38252c2c2bb597623b4bdac068410cbf
Autor:
Avery, Emma F, Kleynhans, Julia N, Ledergerber, Bruno, Schoepf, Isabella C, Thorball, Christian W, Kootstra, Neeltje A, Reiss, Peter, Ryom, Lene, Braun, Dominique L, Thurnheer, Maria C, Marzolini, Catia, Seneghini, Marco, Bernasconi, Enos, Cavassini, Matthias, Buvelot, Hélène, Kouyos, Roger D, Fellay, Jacques, Günthard, Huldrych F, Tarr, Philip E
BACKGROUND People with HIV (PWH) have increased cardiovascular risk. Higher leukocyte count has been associated with coronary artery disease (CAD) events in the general population. It is unknown whether the leukocyte-CAD association also applies to P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6c808af1e5fc18f117193133cefcc62b
Autor:
Griessbach, Alexandra, Chammartin, Frédérique, Abela, Irene A, Amico, Patrizia, Stoeckle, Marcel P, Eichenberger, Anna L, Hasse, Barbara, Braun, Dominique L, Schuurmans, Macé M, Müller, Thomas F, Tamm, Michael, Audigé, Annette, Mueller, Nicolas J, Rauch, Andri, Günthard, Huldrych F, Koller, Michael T, Trkola, Alexandra, Epp, Selina, Amstutz, Alain, Schönenberger, Christof M, Taji Heravi, Ala, Kusejko, Katharina, Bucher, Heiner C, Briel, Matthias, Speich, Benjamin
Publikováno v:
Griessbach, Alexandra; Chammartin, Frédérique; Abela, Irene A; Amico, Patrizia; Stoeckle, Marcel P; Eichenberger, Anna L; Hasse, Barbara; Braun, Dominique L; Schuurmans, Macé M; Müller, Thomas F; Tamm, Michael; Audigé, Annette; Mueller, Nicolas J; Rauch, Andri; Günthard, Huldrych F; Koller, Michael T; Trkola, Alexandra; Epp, Selina; Amstutz, Alain; Schönenberger, Christof M; ... (2023). Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2: Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2). Open Forum Infectious Diseases, 10(4), ofad150. Oxford University Press 10.1093/ofid/ofad150
Extension of the COVERALL (COrona VaccinE tRiAL pLatform) randomized trial showed noninferiority in antibody response of the third dose of Moderna mRNA-1273 vaccine (95.3% [95% confidence interval {CI}, 91.9%-98.7%]) compared to Pfizer-BioNTech BNT16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a7adf3ea3374e0888e466dd6bdd7e42
Autor:
Marzolini, Catia, Cavassini, Matthias, Braun, Dominique L, Hachfeld, Anna, Bernasconi, Enos, Calmy, Alexandra, Schmid, Patrick, Battegay, Manuel, Elzi, Luigia
AIM We previously observed that some individuals on HIV boosted protease inhibitor containing regimen do not achieve their lipid targets despite elevated statin concentrations. This study evaluated whether the common single polymorphism c.521T>C in S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f4ae8be92c323b9cb8c14d8c76c492b
Autor:
Zeeb, Marius, Tepekule, Burcu, Kusejko, Katharina, Reiber, Claudine, Kälin, Marisa, Bartl, Lena, Notter, Julia, Furrer, Hansjakob, Hoffmann, Matthias, Hirsch, Hans H, Calmy, Alexandra, Cavassini, Matthias, Labhardt, Niklaus D, Bernasconi, Enos, Braun, Dominique L, Günthard, Huldrych F, Kouyos, Roger D, Nemeth, Johannes
BACKGROUND People with human immunodeficiency virus type 1 (HIV) (PWH) are frequently coinfected with Mycobacterium tuberculosis (MTB) and at risk for progressing from asymptomatic latent TB infection (LTBI) to active tuberculosis (TB). LTBI testing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0365a2c52d22dbcf94434364f5c1e31d
Autor:
Kusejko, Katharina, Salazar-Vizcaya, Luisa, Shah, Cyril, Stöckle, Marcel, Béguelin, Charles, Schmid, Patrick, Ongaro, Marie, Darling, Katherine, Bernasconi, Enos, Rauch, Andri, Kouyos, Roger D, Günthard, Huldrych F, Böni, Jürg, Fehr, Jan S, Braun, Dominique L, Swiss HIV Cohort Study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______885::40378366743770907f2b1728123d096e
https://www.zora.uzh.ch/id/eprint/223123/
https://www.zora.uzh.ch/id/eprint/223123/